TNFSF11, initially recognized as a crucial regulator of bone metabolism via the RANK/RANKL/OPG pathway, has been increasingly implicated in the progression of various cancers, as well as in their tendency to undergo epithelial-mesenchymal transition [29, 38]. The gene discussed is TNFSF11; the disease is cancer.